Combined QM/MM Study of Thyroid and Steroid Hormone Analogue Interactions with αvβ3 Integrin

Recent biochemical studies have identified a cell surface receptor for thyroid and steroid hormones that bind near the arginine-glycine-aspartate (RGD) recognition site on the heterodimeric αvβ3 integrin. To further characterize the intermolecular interactions for a series of hormone analogues, combined quantum mechanical and molecular mechanical (QM/MM) methods were used to calculate their interaction energies. All calculations were performed in the presence of either calcium (Ca2+) or magnesium (Mg2+) ions. These data reveal that 3,5′-triiodothyronine (T3) and 3,5,3′,5′-tetraiodothyroacetic acid (T4ac) bound in two different modes, occupying two alternate sites, one of which is along the Arg side chain of the RGD cyclic peptide site. These orientations differ from those of the other ligands whose alternate binding modes placed the ligands deeper within the RGD binding pocket. These observations are consistent with biological data that indicate the presence of two discrete binding sites that control distinct downstream signal transduction pathways for T3.

[1]  W. R. Wadt,et al.  Ab initio effective core potentials for molecular calculations. Potentials for main group elements Na to Bi , 1985 .

[2]  W. R. Wadt,et al.  Ab initio effective core potentials for molecular calculations. Potentials for K to Au including the outermost core orbitals , 1985 .

[3]  J. Baxter,et al.  A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor. , 1998, Chemistry & biology.

[4]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..

[5]  B. Finzel,et al.  Cation binding to the integrin CD11b I domain and activation model assessment. , 1998, Structure.

[6]  Li Zhang,et al.  Ligand Binding to Integrins* , 2000, The Journal of Biological Chemistry.

[7]  M. Humphries,et al.  Integrin structure. , 2000, Biochemical Society transactions.

[8]  N. Hogg,et al.  The regulation of integrin function by Ca(2+). , 2000, Biochimica et biophysica acta.

[9]  Thilo Stehle,et al.  Crystal Structure of the Extracellular Segment of Integrin αVβ3 , 2001, Science.

[10]  Thilo Stehle,et al.  Crystal Structure of the Extracellular Segment of Integrin αVβ3 in Complex with an Arg-Gly-Asp Ligand , 2002, Science.

[11]  Horst Kessler,et al.  The structures of integrins and integrin-ligand complexes: implications for drug design and signal transduction. , 2002, Angewandte Chemie.

[12]  Horst Kessler,et al.  A Three‐State Mechanism of Integrin Activation and Signal Transduction for Integrin αvβ3 , 2002 .

[13]  Linda G Griffith,et al.  Simulations of cell-surface integrin binding to nanoscale-clustered adhesion ligands. , 2002, Biophysical journal.

[14]  Jianxun Lei,et al.  3,3′,5-Triiodo-l-thyronine Up-regulation of Na,K-ATPase Activity and Cell Surface Expression in Alveolar Epithelial Cells Is Src Kinase- and Phosphoinositide 3-Kinase-dependent* , 2004, Journal of Biological Chemistry.

[15]  K. Schulten,et al.  Structural insights into how the MIDAS ion stabilizes integrin binding to an RGD peptide under force. , 2004, Structure.

[16]  Paul Webb,et al.  Selective activation of thyroid hormone signaling pathways by GC-1: a new approach to controlling cholesterol and body weight , 2004, Trends in Endocrinology & Metabolism.

[17]  K. Gottschalk,et al.  A computational model of transmembrane integrin clustering. , 2004, Structure.

[18]  Ioan Andricioaei,et al.  Conversion between three conformational states of integrin I domains with a C-terminal pull spring studied with molecular dynamics. , 2004, Structure.

[19]  F. B. Davis,et al.  The Proangiogenic Action of Thyroid Hormone Analogue GC-1 Is Initiated at an Integrin , 2005, Journal of cardiovascular pharmacology.

[20]  M. Arnaout,et al.  Integrin structure, allostery, and bidirectional signaling. , 2005, Annual review of cell and developmental biology.

[21]  L. Moeller,et al.  Cytosolic action of thyroid hormone leads to induction of hypoxia-inducible factor-1alpha and glycolytic genes. , 2005, Molecular endocrinology.

[22]  F. B. Davis,et al.  Membrane receptors mediating thyroid hormone action , 2005, Trends in Endocrinology & Metabolism.

[23]  Jing Kong,et al.  Lennard–Jones parameters for the combined QM/MM method using the B3LYP/6‐31G*/AMBER potential , 2005, J. Comput. Chem..

[24]  Hung-Yun Lin,et al.  Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. , 2005, Endocrinology.

[25]  Hung-Yun Lin,et al.  Integrin αVβ3 contains a receptor site for resveratrol , 2006 .

[26]  Shawn T. Brown,et al.  Advances in methods and algorithms in a modern quantum chemistry program package. , 2006, Physical chemistry chemical physics : PCCP.

[27]  Hung-Yun Lin,et al.  Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells. , 2006, Cancer research.

[28]  F. B. Davis,et al.  Proangiogenesis action of the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) is initiated at the cell surface and is integrin mediated. , 2006, Endocrinology.

[29]  Hung-Yun Lin,et al.  Thyroid hormone is a MAPK-dependent growth factor for thyroid cancer cells and is anti-apoptotic , 2007, Steroids.

[30]  Jing Kong,et al.  Large-Scale QM/MM Calculations of Electronic Excitations in Yellow Protein: Toward Petascale Level of Protein Calculations , 2007, 2007 IEEE 7th International Symposium on BioInformatics and BioEngineering.

[31]  F. B. Davis,et al.  Molecular modeling of the thyroid hormone interactions with αvβ3 integrin , 2007, Steroids.

[32]  Hung-Yun Lin,et al.  Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: both actions are integrin and ERK mediated. , 2007, Carcinogenesis.

[33]  B. Coller,et al.  Functional and computational studies of the ligand‐associated metal binding site of β3 integrins , 2008, Proteins.

[34]  R. Longhi,et al.  Structural Basis for the Interaction of isoDGR with the RGD-binding Site of αvβ3 Integrin* , 2008, Journal of Biological Chemistry.

[35]  F. B. Davis,et al.  L-Thyroxine vs. 3,5,3'-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. , 2009, American journal of physiology. Cell physiology.

[36]  F. B. Davis,et al.  Androgen-induced human breast cancer cell proliferation is mediated by discrete mechanisms in estrogen receptor-α-positive and -negative breast cancer cells , 2009, The Journal of Steroid Biochemistry and Molecular Biology.

[37]  P. Davis,et al.  Molecular aspects of thyroid hormone actions. , 2010, Endocrine reviews.

[38]  F. B. Davis,et al.  Membrane receptor for thyroid hormone: physiologic and pharmacologic implications. , 2011, Annual review of pharmacology and toxicology.

[39]  F. B. Davis,et al.  Identification and functions of the plasma membrane receptor for thyroid hormone analogues. , 2011, Discovery medicine.